Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLAUKOS CorpGKOS · Entity 3510 | Director | May 28, 2026 | June 23, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | Director · Chief Executive Officer | September 02, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLAUKOS Corp
Report date May 28, 2026 · Filed June 23, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.52 · Expires 2036-05-28 | Direct | 2,987 |
Reported balance
After 2026-05-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 2,987 · Balance 2,987 F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above.
F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
VERACYTE, INC.
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 432,073 |
Reported balance
After 2026-09-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-02 · Tax withholding · Disposed 8,782 · Balance 432,073 F1: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2: Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.
F2: Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ILLUMINA, INC.
Report date December 31, 2018 · Filed February 12, 2019
Section 16 reporting ended · disclosed 2019-02-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Children | 300 |
Reported balance
After 2018-12-27 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-12-27 · Gift · Acquired 300 · Balance 300 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 15,238 |
Reported balance
After 2018-12-27 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-12-27 · Gift · Disposed 300 · Balance 15,238 |
| Common StockSEC Table I · non-derivative | Direct | 5,328 |
Reported balance
Holding disclosure · report date 2018-12-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,328 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2024 Filed Jun 4, 2024 00:55 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015234 · form4-06042024_120631.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,076 F1 · security: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 5,990 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:45 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013385 · form4-05162024_110513.xml · derivative · entry 5 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2025-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F7 · derivative.exercise_date: This option was granted on July 23, 2015 and has a three-year vesting schedule in which one-third vests on each of the first three anniversaries of the grant date, such that the stock option vests in full on the three-year anniversary of the grant date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:45 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,000 | $113.68 | $227,360.00 |
DisclosureSEC source: 0001415889-24-013385 · form4-05162024_110513.xml · nonDerivative · entry 4 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,360 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $113.40 to $113.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:45 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,200 | $112.91 | $248,402.00 |
DisclosureSEC source: 0001415889-24-013385 · form4-05162024_110513.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,360 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $112.40 - $113.39). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:45 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,050 | $111.82 | $229,231.00 |
DisclosureSEC source: 0001415889-24-013385 · form4-05162024_110513.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,560 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $111.39 - $112.38). The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:45 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 6,250 | $32.00 | $200,000.00 |
DisclosureSEC source: 0001415889-24-013385 · form4-05162024_110513.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:49 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 5,971 | $21.10 | $125,988.10 |
DisclosureSEC source: 0001384101-24-000044 · wk-form4_1710881378.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,740 F2 · kind: The reporting person is reporting the withholding of 5,971 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 11,780 Performance Stock Units vested on March 15, 2024 and does not represent a sale by the reporting person. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:49 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 11,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000044 · wk-form4_1710881378.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,711 F1 · kind: Represents the acquisition of restricted stock units ("RSUs") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2023, as reflected in the financial statements and certified by the Compensation Committee of the Board of Directors on March 15, 2024. The RSUs vested March 15, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:37 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 114,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000041 · wk-form4_1709933854.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,931 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:27 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 13,286 | $24.00 | $318,864.00 |
DisclosureSEC source: 0001384101-24-000024 · wk-form4_1709677638.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,207 F1 · kind: The reporting person is reporting the withholding of 1,613, 1,784 and 9,889 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925, 3,534 and 19,511 Restricted Stock Units granted on June 1, 2021, March 3, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 611 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:09 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006435 · form4-03052024_010346.xml · derivative · entry 5 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 6,250 shares Expires 2025-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F7 · derivative.exercise_date: This option was granted on July 23, 2015 and has a three-year vesting schedule in which one-third vests on each of the first three anniversaries of the grant date, such that the stock option vests in full on the three-year anniversary of the grant date. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:09 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,313 | $91.21 | $210,968.73 |
DisclosureSEC source: 0001415889-24-006435 · form4-03052024_010346.xml · nonDerivative · entry 4 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,360 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $90.96 - $91.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:09 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,500 | $90.54 | $135,810.00 |
DisclosureSEC source: 0001415889-24-006435 · form4-03052024_010346.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,673 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $89.51 - $90.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:09 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 2,437 | $88.76 | $216,308.12 |
DisclosureSEC source: 0001415889-24-006435 · form4-03052024_010346.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,173 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $88.45 - $89.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 01:09 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 6,250 | $32.00 | $200,000.00 |
DisclosureSEC source: 0001415889-24-006435 · form4-03052024_010346.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,840 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:41 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000629 · form4-01042024_090106.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,398 F1 · security: Represents a grant of restricted stock units received by the Reporting Person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 11,536 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 02, 2024 Filed Mar 5, 2024 01:07 UTC Amendment | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006433 · form4a-03052024_010346.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,360 F1 · shares: This Form 4A amends a Form 4 filed January 4, 2024 that incorrectly reported the number of restricted stock unites ("RSUs") granted to the Reporting Person on January 2, 2024 as 1,082. The correct number of RSUs granted was 1,044, as shown above. F2 · balance_after: Includes 9,740 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001415889-23-016668 · form4-12192023_011238.xml · derivative · entry 6 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires 2025-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F7 · derivative.exercise_date: This option was granted on July 23, 2015 and has a three-year vesting schedule in which one-third vests on each of the first three anniversaries of the grant date, such that the stock option vests in full on the three-year anniversary of the grant date. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001415889-23-016668 · form4-12192023_011238.xml · derivative · entry 5 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F6 · derivative.exercise_date: This option was granted on July 10, 2014 and has a three-year vesting schedule in which one-third vests on each of the first three anniversaries of the grant date, such that the stock option vests in full on the three-year anniversary of the grant date. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 7,044 | $76.35 | $537,809.40 |
DisclosureSEC source: 0001415889-23-016668 · form4-12192023_011238.xml · nonDerivative · entry 4 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,316 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $76.00 to $76.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 10,454 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 9,206 | $75.61 | $696,065.66 |
DisclosureSEC source: 0001415889-23-016668 · form4-12192023_011238.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,360 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $75.00 to $75.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 10,454 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 6,250 | $32.00 | $200,000.00 |
DisclosureSEC source: 0001415889-23-016668 · form4-12192023_011238.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 10,454 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Read SEC document |
| December 14, 2023 Filed Dec 19, 2023 01:40 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 10,000 | $7.28 | $72,750.00 |
DisclosureSEC source: 0001415889-23-016668 · form4-12192023_011238.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 10,454 restricted stock units that have not yet vested or not yet been delivered to the Reporting Person. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:45 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,203 | $26.54 | $85,007.62 |
DisclosureSEC source: 0001384101-23-000171 · wk-form4_1701812704.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,882 F1 · kind: The reporting person is reporting the withholding of 1,451 and 1,752 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926 and 3,533 Restricted Stock Units granted on June 1, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 20:33 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,204 | $26.70 | $85,546.80 |
DisclosureSEC source: 0001384101-23-000149 · wk-form4_1694032399.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,085 F1 · kind: The reporting person is reporting the withholding of 1,451 and 1,753 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925 and 3,534 Restricted Stock Units granted on June 1, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 593 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:48 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,203 | $26.72 | $85,584.16 |
DisclosureSEC source: 0001384101-23-000081 · wf-form4_168608451258881.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,696 F1 · kind: The reporting person is reporting the withholding of 1,451 and 1,752 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926 and 3,533 Restricted Stock Units granted on June 1, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 00:05 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009283 · form4-06062023_120654.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,316 F1 · security: Represents a grant of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 14,818 restricted stock units that have not vested or been delivered to the Reporting Person. Read SEC document |
| March 06, 2023 Filed Mar 10, 2023 00:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 128,869 | $0.00 Strike: $23.73 | $0.00 |
DisclosureSEC source: 0001384101-23-000038 · wf-form4_167840701421008.xml · derivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,869 Underlying: Common Stock · 128,869 shares Expires 2033-03-06 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| March 06, 2023 Filed Mar 10, 2023 00:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 78,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-23-000038 · wf-form4_167840701421008.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,899 F1 · kind: Restricted stock units awarded on March 6, 2023 vest 25% on March 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 01:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 6,029 | $24.10 | $145,298.90 |
DisclosureSEC source: 0001384101-23-000029 · wf-form4_167789223883767.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,855 F1 · kind: The reporting person is reporting the withholding of 1,150 and 4,879 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925 and 14,134 Restricted Stock Units granted on June 1, 2021 and March 3, 2022, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 585 shares of common stock purchased on January 31, 2023 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:02 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000400 · form4-01042023_110138.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,086 F1 · security: Represents a grant of restricted stock units received by the Reporting Person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 9,830 restricted stock units that have not vested or been delivered to the Reporting Person. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 22:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,012 | $29.14 | $29,489.68 |
DisclosureSEC source: 0001384101-22-000151 · wf-form4_167036462968825.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,299 F1 · kind: The reporting person is reporting the withholding of 1,012 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926 Restricted Stock Units granted on June 1, 2021 and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:56 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,012 | $19.18 | $19,410.16 |
DisclosureSEC source: 0001384101-22-000130 · wf-form4_166258419155181.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,311 F1 · kind: The reporting person is reporting the withholding of 1,012 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925 Restricted Stock Units granted on June 1, 2021 and does not represent a sale by the reporting person. F2 · balance_after: Includes 562 shares of common stock purchased on July 29, 2022 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 12:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | PurchaseCommon Stock | 60,000 | $16.33 | $980,094.00 |
DisclosureSEC source: 0001384101-22-000083 · wf-form4_165512274967029.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,761 F1 · price: Represents weighted average purchase price. Purchase prices for the transactions range from $16.24 to $16.40. Detailed information regarding the number of shares purchased at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 23:52 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 4,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-068664 · tm2217841-2_4seq1.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,186 F1 · security: Represents a grant of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 8,504 restricted stock units that have not yet vested or been delivered to the Reporting Person, and 1,184 restricted stock units that have vested but have not yet been delivered to the Reporting Person based upon the Reporting Person's election to defer delivery. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 4,047 | $18.23 | $73,776.81 |
DisclosureSEC source: 0001384101-22-000076 · wf-form4_165454707721517.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,761 F1 · kind: The reporting person is reporting the withholding of 4,047 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 11,701 Restricted Stock Units granted on June 1, 2021 and does not represent a sale by the reporting person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 21:37 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 103,026 | $0.00 Strike: $26.02 | $0.00 |
DisclosureSEC source: 0001384101-22-000048 · wf-form4_164668902627659.xml · derivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,026 Underlying: Common Stock · 103,026 shares Expires 2032-03-03 F3 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 21:37 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 56,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000048 · wf-form4_164668902627659.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,808 F1 · kind: Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. F2 · balance_after: Includes 464 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2022. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:57 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001663 · tm221974-3_4seq1.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,822 F1 · security: Represents a grant of restricted stock units received by the reporting person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 4,140 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-077833 · tm2119039-2_4seq1.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,064 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 3,566 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:02 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 138,051 | $0.00 Strike: $36.60 | $0.00 |
DisclosureSEC source: 0001384101-21-000092 · wf-form4_162275411446342.xml · derivative · entry 2 Stapley Marc · CIK 0001539796 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,051 Underlying: Common Stock · 138,051 shares Expires 2031-06-01 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on June 1, 2022, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:02 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 46,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-21-000092 · wf-form4_162275411446342.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,807 F1 · kind: Restricted stock units awarded on June 1, 2021 vest 25% on June 2, 2022 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 02:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-001755 · a4.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,682 F1 · security: Represents a grant of restricted stock units received by the reporting person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 5,084 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| June 03, 2020 Filed Jun 6, 2020 00:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019053 · form4.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,498 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 5,273 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:30 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-000903 · a4.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,598 F1 · security: Represents a grant of restricted stock units received by the reporting person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 4,026 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 30, 2019 Filed Jun 1, 2019 00:06 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 2,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-033242 · a4.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,225 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 4,044 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| January 02, 2019 Filed Jan 16, 2019 21:28 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-000315 · primarydocument.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,572 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 6,024 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| December 27, 2018 Filed Feb 12, 2019 22:33 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005451 · form5.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · EVP Strategy & Corp Developmt 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 15,238 Read SEC document |
| December 27, 2018 Filed Feb 12, 2019 22:33 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005451 · form5.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · EVP Strategy & Corp Developmt 10b5-1 filing: Not disclosed Ownership: Indirect · By Children Disclosed balance after: 300 Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 22:17 UTC | ILLUMINA, INC. ILMN · Entity 3137 | SaleCommon Stock | 200 | $333.28 | $66,656.00 |
DisclosureSEC source: 0001127602-18-035577 · form4.xml · nonDerivative · entry 6 Stapley Marc · CIK 0001539796 · EVP Strategy & Corp Developmt 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,957 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 200 shares sold ranging from $332.87 to $333.69 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. F6 · balance_after: Includes 1,000 shares previously held by Mr. Stapley's family trust which were transferred to Mr. Stapley and are now owned directly. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.